What This Advancement Means for Equines and Equestrians
Equine medicine has continued to advance in ways that improve quality of life for horses while giving horse owners greater confidence in long term care decisions. A recent milestone is the FDA approval of Dechra’s Zygolide tablets, which expands available options for Equine Cushing’s Disease treatment. This approval is especially meaningful because Equine Cushing’s Disease is one of the most common endocrine disorders affecting older horses.
With Zygolide now approved by the U.S. Food and Drug Administration, managing this chronic condition may become more accessible and […]


